It is worth noting that the presence of tumor-specific CD8+ Trm cells in cancer patients is now considered a strong predictor of survival [41,42] since these cells play a major role in patrolling the growth of solid tumors, thus precluding the development of clinically relevant pathologies [43]. This evidence concerns the gene CD8A and neoplasm.